🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
HL237 is a new autoimmune therapeutic agent for rheumatoid arthritis, inclu...
Status
Unknown
Location
The Catholic University of Korea, Seoul ST. Mary's Hospital
Start Date
2018-12-24
Trial ID
NCT03896594
Treatments Being Tested
HL237 is a new autoimmune therapeutic agent for rheumatoid arthritis, inclu...
Status
Completed
Location
The catholic university of korea seoul ST. mary's hospital
Start Date
2017-06-26
Trial ID
NCT03278470
Treatments Being Tested
The purpose of this clinical trial is to determine the optimal dose of HL23...
Status
Unknown
Location
The Catholic University of Korea Seoul ST.MARY'S Hospital
Start Date
2020-09-10
Trial ID
NCT04638426
Treatments Being Tested
This study aims to evaluate the pharmacokinetic interaction between HL237 a...
Status
Unknown
Location
The Korea Univertisy Anam Hospital
Start Date
2020-08-22
Trial ID
NCT04633733
Treatments Being Tested